|
GB202103080D0
|
|
Cancer biomarkers
|
|
GB202020493D0
|
|
Cancer biomarkers
|
|
WO2021075494A1
|
|
Method for producing centanafadine
|
|
WO2021071890A1
|
|
2'-deoxy-2',2'-difluorotetrahydrouridines with high purity and methods of making the same
|
|
GB202013476D0
|
|
Cancer biomarkers
|
|
WO2021002480A1
|
|
System and method for behavioral anomaly detection based on an adherence volatility metric
|
|
JP2021001168A
|
|
Levocarnitine-containing tablet
|
|
WO2020256156A1
|
|
A dynamically distorted time warping distance measure between continuous bounded discrete-time series
|
|
WO2020246602A1
|
|
Tetra-functional chemical probe and method for identifying target membrane protein from living cell or living tissue by using said probe
|
|
US2020352976A1
|
|
Hypomethylating agents for use in treatment of cancer
|
|
WO2020196816A1
|
|
Benzoazepine compound-containing pharmaceutical composition
|
|
WO2020196814A1
|
|
Benzoazepine compound-containing freeze-dried composition
|
|
WO2020196665A1
|
|
Antitumor composition
|
|
WO2020184670A1
|
|
Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine
|
|
WO2020179924A1
|
|
Methods and apparatus for activation of a wearable patch
|
|
WO2020179922A1
|
|
Methods and apparatus for a frame surrounding a wearable patch
|
|
TW202100175A
|
|
Composition containing plant-derived extract and/or plant-derived processed product
|
|
WO2020153479A2
|
|
Elastic wearable sensor
|
|
WO2020158548A1
|
|
Method for producing benzoazepine compound
|
|
JP2020109086A
|
|
Pharmaceutical composition
|
